NHP.H Stock Overview
Develops and commercializes evidence-based botanical products for the healthcare in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Lumiera Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.005 |
| 52 Week Low | CA$0.005 |
| Beta | 1.08 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -87.50% |
| 5 Year Change | -95.24% |
| Change since IPO | -97.92% |
Recent News & Updates
Shareholder Returns
| NHP.H | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -6.0% | 0.9% |
| 1Y | n/a | 37.6% | 15.8% |
Return vs Industry: Insufficient data to determine how NHP.H performed against the Canadian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how NHP.H performed against the Canadian Market.
Price Volatility
| NHP.H volatility | |
|---|---|
| NHP.H Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.3% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in CA Market | 16.6% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: NHP.H has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NHP.H's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.lumiera.ca |
Lumiera Health Inc., together with its subsidiaries, develops and commercializes evidence-based botanical products for the healthcare in Canada. The company sells oral and topical botanical agents to manage unmet medical needs; and solutions for sleep-aids and pain management. It offers herbal tonics and supplements for cardiovascular health, stress relief, bones, joints and muscle mobility, and energy and immunity under the Holizen brand; sleep aid products under the Bazzzics brand; and pain relief cream under the Awaye brand.
Lumiera Health Inc. Fundamentals Summary
| NHP.H fundamental statistics | |
|---|---|
| Market cap | CA$849.83k |
| Earnings (TTM) | -CA$1.73m |
| Revenue (TTM) | CA$433.29k |
2.0x
P/S Ratio-0.5x
P/E RatioIs NHP.H overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NHP.H income statement (TTM) | |
|---|---|
| Revenue | CA$433.29k |
| Cost of Revenue | CA$377.48k |
| Gross Profit | CA$55.82k |
| Other Expenses | CA$1.78m |
| Earnings | -CA$1.73m |
Last Reported Earnings
Aug 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.01 |
| Gross Margin | 12.88% |
| Net Profit Margin | -398.18% |
| Debt/Equity Ratio | -95.3% |
How did NHP.H perform over the long term?
See historical performance and comparison